Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis

Background and aimsColorectal cancer (CRC) ranks as the fourth most frequently diagnosed cancer worldwide. CRCs that arise proximally or distally to the splenic flexure show differences in epidemiologic incidence, morphology, and molecular alterations, suggesting the existence of two categories of CRC based on the site of origin. The aim of the present work is to investigate the histological and molecular differences between CRCs located proximally and distally to the splenic flexure, and their potential involvement in tumor prognosis and therapeutic strategies.MethodsWe evaluated 120 patients affected by sporadic CRC for clinicopathologic features, microsatellite instability (MSI), loss of heterozygosity (LOH) of chromosomes 18q, 8p, and 4p; they were also investigated for hMlh1, hMsh2, Fhit, p27, and Cox-2 immunostaining.ResultsThe mucinous histotype was more frequent in the proximal than in the distal CRCs (p<0.004). The frequency of MSI phenotype was higher in proximal than in distal tumors (p<0.001); moreover, reduced or absent hMlh1, Fhit, p27 immunohistochemical expressions were more frequent in proximal than in distal tumors (p<0.001 and 0.01 for p27). In contrast, the frequency of LOH in 18q was higher in distal than in proximal tumors (p=0.002). No significant differences were observed between proximal and distal tumors in the frequency of LOH in 8p and altered expression of hMsh2 and p53 protein.ConclusionThese different features may reflect different genetic pathways of carcinogenesis and support the hypothesis of a different mechanism of cancer development between the proximal and the distal colon, with potential implications in the therapeutic approach.

[1]  M. Kondo,et al.  Expression of cyclooxygenase-1 and -2 in human colorectal cancer. , 1995, Cancer research.

[2]  L. Aaltonen,et al.  Genomic instability in colorectal cancer: relationship to clinicopathological variables and family history. , 1993, Cancer research.

[3]  H. Kawasaki,et al.  Reduced Fhit expression is associated with mismatch repair deficiency in human advanced colorectal carcinoma , 2002, British Journal of Cancer.

[4]  B. Leggett,et al.  Prognostic significance of extensive microsatellite instability in sporadic clinicopathological stage C colorectal cancer , 2000, The British journal of surgery.

[5]  L. D. Barnes,et al.  Replacement of Fhit in cancer cells suppresses tumorigenicity. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[6]  J. Masferrer,et al.  COX‐2 is expressed in human pulmonary, colonic, and mammary tumors , 2000, Cancer.

[7]  G. Lapertosa,et al.  Primary mucinous adenocarcinomas and signet-ring cell carcinomas of colon and rectum. , 1994, Oncology.

[8]  C. Bordi,et al.  Abnormal Fhit protein expression and high frequency of microsatellite instability in sporadic colorectal cancer. , 2004, European journal of cancer.

[9]  H. Weiss,et al.  Prognostic Significance of p27kip-1 Expression in Colorectal Adenocarcinomas Is Associated with Tumor Stage , 2004, Clinical Cancer Research.

[10]  M. Coleman,et al.  Survival of cancer patients in europe—The EUROCARE study , 1995, Cancer Causes & Control.

[11]  M. Tomonaga,et al.  Alterations of the p27KIP1 gene in non-Hodgkin's lymphomas and adult T-cell leukemia/lymphoma. , 1995, Blood.

[12]  M. Loda,et al.  Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas , 1997, Nature Medicine.

[13]  G. Capellá,et al.  Prospective assessment of allelic losses at 4p14-16 in colorectal cancer: two mutational patterns and a locus associated with poorer survival. , 1999, Clinical cancer research : an official journal of the American Association for Cancer Research.

[14]  David Joseph,et al.  Association of tumour site and sex with survival benefit from adjuvant chemotherapy in colorectal cancer , 2000, The Lancet.

[15]  H. Koeffler,et al.  p27/Kip1 mutation found in breast cancer. , 1996, Cancer research.

[16]  H. McLeod,et al.  Tumour markers of prognosis in colorectal cancer , 1999, British Journal of Cancer.

[17]  T. Pawlik,et al.  Clinicopathologic features in colorectal cancer patients with microsatellite instability. , 2004, Mutation research.

[18]  M. Beckmann,et al.  Clinical impact of detection of loss of heterozygosity of BRCA1 and BRCA2 markers in sporadic breast cancer. , 1996, British Journal of Cancer.

[19]  K. Nephew,et al.  Epigenetic gene silencing in cancer initiation and progression. , 2003, Cancer letters.

[20]  O. Dent,et al.  Methodology and reporting in studies of local recurrence after curative excision of the rectum for cancer , 2001, The British journal of surgery.

[21]  R. Gafà,et al.  Chromosome 18q allelic loss and prognosis in stage II and III colon cancer , 1998, International journal of cancer.

[22]  H. Zhang,et al.  Loss of p27 expression predicts poor prognosis in patients with Dukes' B stage or proximal colorectal cancer. , 2001, International journal of oncology.

[23]  D. Kerr,et al.  The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment. , 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  R. Gafà,et al.  Sporadic colorectal adenocarcinomas with high‐frequency microsatellite instability , 2000, Cancer.

[25]  I. Kirsch,et al.  Prognostic significance of DNA replication errors in young patients with colorectal cancer. , 1998, Annals of surgery.

[26]  American Joint Committee on Cancer Prognostic Factors Consensus Conference , 1999 .

[27]  R. DuBois,et al.  Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase 2 , 1995, Cell.

[28]  A. Benhamiche,et al.  Are there several colorectal cancers? Epidemiological data. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[29]  P. Quirke,et al.  DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer: a molecular study , 2002, The Lancet.

[30]  P J Catalano,et al.  Molecular predictors of survival after adjuvant chemotherapy for colon cancer. , 2001, The New England journal of medicine.

[31]  H. Höfler,et al.  Loss of heterozygosity and microsatellite instability in de novo versus ex-adenoma carcinomas of the colorectum. , 1998, The American journal of pathology.

[32]  Detection of DCC and Ki‐ras gene alterations in colorectal carcinoma tissue as prognostic markers for liver metastatic recurrence , 1996, Cancer.

[33]  T. Fleming,et al.  Surgical adjuvant therapy of large-bowel carcinoma: an evaluation of levamisole and the combination of levamisole and fluorouracil. The North Central Cancer Treatment Group and the Mayo Clinic. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  Emmanuel Mitry,et al.  Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma. , 1990, The New England journal of medicine.

[35]  J. Jass,et al.  Emerging pathways in colorectal-cancer development. , 2002, The Lancet. Oncology.

[36]  P. Holt,et al.  Are right- and left-sided colon neoplasms distinct tumors? , 1997, Digestive diseases.

[37]  T. Hla,et al.  Overexpression of Cyclooxygenase-2 Is Sufficient to Induce Tumorigenesis in Transgenic Mice* , 2001, The Journal of Biological Chemistry.

[38]  K. Sheahan,et al.  The relationship between cyclooxygenase-2 expression and colorectal cancer. , 1999, JAMA.

[39]  B. Iacopetta Are there two sides to colorectal cancer? , 2002, International journal of cancer.

[40]  L. Roncucci,et al.  Evidence for the existence of different types of large bowel tumor: Suggestions from the clinical data of a population‐based registry , 1990, Journal of surgical oncology.

[41]  Carolyn Compton,et al.  American Joint Committee on Cancer prognostic factors consensus conference , 2000, Cancer.

[42]  P. Vihko,et al.  Loss of heterozygosity at 18q21 is indicative of recurrence and therefore poor prognosis in a subset of colorectal cancers , 1999, British Journal of Cancer.

[43]  Z. F. Liu,et al.  Allelic loss of chromosome 18q and prognosis in colorectal cancer. , 1994, The New England journal of medicine.

[44]  A. Ristimäki,et al.  Expression of cyclooxygenase-2 in human lung carcinoma. , 1998, Cancer research.

[45]  J. Kleibeuker,et al.  Change in Anatomic Distribution and Incidence of Colorectal Carcinoma Over a Period of 15 Years , 2002, Diseases of the colon and rectum.

[46]  A. Lindblom Different mechanisms in the tumorigenesis of proximal and distal colon cancers , 2001, Current opinion in oncology.

[47]  K. Dohi,et al.  Mucinous Carcinoma of the Colon and Rectum , 1994 .

[48]  D. Schaid,et al.  Microsatellite instability and 8p allelic imbalance in stage B2 and C colorectal cancers. , 1999, Journal of the National Cancer Institute.

[49]  R. Mariani-Costantini,et al.  Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer. , 2005, Oncology reports.

[50]  R. Rosell,et al.  Allelic loss on chromosome 18q as a prognostic marker in stage II colorectal cancer. , 1998, Gastroenterology.

[51]  J. Ray,et al.  Mucinous carcinoma—Just another colon cancer? , 1993, Diseases of the colon and rectum.

[52]  G. Baretton,et al.  Microsatellite instability, loss of heterozygosity, and loss of hMLH1 and hMSH2 protein expression in endometrial carcinoma. , 2002, Human pathology.

[53]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[54]  [Two colons--two cancers? Proximal or distal adenocarcinoma: arguments for a different carcinogenesis]. , 1995, Bulletin du cancer.

[55]  J. Slingerland,et al.  The prognostic significance of altered cyclin-dependent kinase inhibitors in human cancer. , 1999, Annual review of medicine.

[56]  J. Cheville,et al.  p27kip1: a multifunctional cyclin-dependent kinase inhibitor with prognostic significance in human cancers. , 1999, The American journal of pathology.

[57]  D. Gómez,et al.  Anatomical distribution of colorectal cancer over a 10 year period in a district general hospital: is there a true “rightward shift”? , 2004, Postgraduate Medical Journal.

[58]  Y. Ikeda,et al.  Possibility of different cancer development between the proximal and distal colon: comparison of the distribution between adenomatous polyps and cancer. , 1998, Hepato-gastroenterology.

[59]  F. Piard,et al.  Are there several types of colorectal carcinomas? Correlations with genetic data. , 1999, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

[60]  C. Bordi,et al.  Association Between Recurrence of Sporadic Colorectal Cancer, High Level of Microsatellite Instability, and Loss of Heterozygosity at Chromosome 18q , 2004, Diseases of the colon and rectum.

[61]  K. Shirouzu,et al.  Biological features of sporadic colorectal carcinoma with high-frequency microsatellite instability: special reference to tumor proliferation and apoptosis , 2004, International Journal of Clinical Oncology.

[62]  I. Tomlinson,et al.  Microsatellite instability and the clinicopathological features of sporadic colorectal cancer , 2001, Gut.

[63]  J. Bufill,et al.  Colorectal cancer: evidence for distinct genetic categories based on proximal or distal tumor location. , 1990, Annals of internal medicine.

[64]  James T. L. Mah,et al.  Incidence and Survival of Mucinous Adenocarcinoma of the Colorectum: A Population-Based Study From an Asian Country , 2004, Diseases of the colon and rectum.

[65]  B. Vogelstein,et al.  A genetic model for colorectal tumorigenesis , 1990, Cell.

[66]  P. Modrich,et al.  Mechanisms and biological effects of mismatch repair. , 1991, Annual review of genetics.

[67]  K. Kinzler,et al.  Genetic instability in colorectal cancers , 1997, Nature.

[68]  P. Fleshner,et al.  Age and sex distribution of patients with colorectal cancer , 1989, Diseases of the colon and rectum.

[69]  A. Sonnenberg,et al.  Continued Rightward Shift of Colorectal Cancer , 2002, Diseases of the colon and rectum.

[70]  P. Chen,et al.  Clinicopathological study of colorectal mucinous carcinoma in Taiwan: A multivariate analysis , 1996, Journal of gastroenterology and hepatology.

[71]  R. DuBois,et al.  Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potential. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[72]  R. Lothe,et al.  Genetic tumor markers with prognostic impact in Dukes' stages B and C colorectal cancer patients. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[73]  N. Bundred,et al.  COX-2 expression is associated with an aggressive phenotype in ductal carcinoma in situ , 2004, British Journal of Cancer.

[74]  R. Roetzheim,et al.  Predictors of proximalvs. distal colorectal cancers , 2001, Diseases of the colon and rectum.

[75]  T. Yeatman,et al.  Cyclooxygenase-2 expression in right- and left-sided colon cancer: a rationale for optimization of cyclooxygenase-2 inhibitor therapy. , 2004, Clinical colorectal cancer.

[76]  A. Chapelle,et al.  Mismatch repair gene defects in sporadic colorectal cancers with microsatellite instability , 1995, Nature Genetics.

[77]  N. Tanigawa,et al.  Prognostic Significance of p27kip1 Protein Expression and Spontaneous Apoptosis in Patients with Colorectal Adenocarcinomas , 2000, Oncology.

[78]  E. Van Cutsem,et al.  Molecular and genetic defects in colorectal tumorigenesis. , 2002, Best practice & research. Clinical gastroenterology.

[79]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[80]  D. Schaid,et al.  Microsatellite instability in colorectal cancer: different mutator phenotypes and the principal involvement of hMLH1. , 1998, Cancer research.

[81]  R. DuBois,et al.  Cyclooxygenase Regulates Angiogenesis Induced by Colon Cancer Cells , 1998, Cell.

[82]  P. Bunn,et al.  Ki-ras mutation and p53 overexpression predict the clinical behavior of colorectal cancer: a Southwest Oncology Group study. , 1998, Cancer research.